Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Mercuryfilling1on May 18, 2022 10:13am
122 Views
Post# 34692071

RE:Shorts

RE:Shorts
Charly50 wrote:
....man could also say the price gap is closed
and the shorties have to stock up.


Sorry Charley, but it won’t work that way (IMO), at least not for a while yet.. Strategic partnerships are nothing new for Evotec and 20 million euros is chump change to them…lots of upside if things go well and a nice tax write off if things go south.
Also, strategic partnerships don’t always mean the SP will rise. As an example: my other risky stock is GENM. Wheaton Precious Metals gave GENM in March this year a 240 million stream with 40 million upfront for initial construction costs related to its mine development. As soon as this great news was released, the SP immediately started a drift down from $1.00 to where it sits today ($0.75). Oh, and BTW, their IR team is stellar…but makes no difference. DonkeyFeathers has alluded to this for quite some time. If they want your shares at a certain price, they’ll do whatever it takes. 
 
Wonder if Witkowski will be standing at the podium this June. Hope so, as that would help things along. In the meantime enjoy the spring weather!

<< Previous
Bullboard Posts
Next >>